Ameba Capital is a Chinese early-stage venture capital firm based in Shanghai, China, making investments across education / edtech, medical devices and healthcare, new energy and clean technology, and information technology sectors primarily in China and adjacent Asian markets. The firm was founded by partners with historical connections to the Alibaba Group ecosystem, and operates as a Chinese early-stage specialist investor. The firm's name ''Ameba'' references the single-celled organism that the Japanese management-guru Kazuo Inamori (founder of Kyocera Corporation) popularised as an organisational-management philosophy (''Ameba Management'' aEUR" breaking large organisations into small self-managing ''cells''), a distinctive branding choice. Ameba Capital has raised multiple USD- and RMB-denominated institutional funds with aggregate AUM in the USD several hundred million range. The firm operates in the broader Chinese early-stage VC ecosystem alongside firms such as Matrix Partners China, Sequoia Capital China (HongShan), IDG Capital, and GGV Capital. Detailed public information about current fund vintages is partially documented in mainstream Chinese / English-language financial-industry databases for this specific URL.